A coalition of organisations linked to the US hemp market has released the first part of a series of policy recommendations – while one CBD firm has been referred to the US Federal Trade Commission over extravagant health claims
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields